| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers O > Headlines for OSI Pharmaceuticals Inc. > News item |
OSI Pharmaceuticals completes acquisition of Eyetech
New York, Nov. 14 - OSI Pharmaceuticals, Inc. said it completed its acquisition of Eyetech Pharmaceuticals, Inc.
OSI paid $685 million in cash and issued 5.7 million shares.
For each share, Eyetech investors received $15 and 0.12275 shares of OSI stock.
OSI is a Melville, N.Y., company concentrating on cancer, eye diseases and diabetes.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.